Article(id=1236357011147903118, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1236357010644586638, articleNumber=null, orderNo=null, doi=null, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=null, receivedDateStr=null, revisedDate=null, revisedDateStr=null, acceptedDate=1694966400000, acceptedDateStr=2023-09-18, onlineDate=1772700081860, onlineDateStr=2026-03-05, pubDate=1702569600000, pubDateStr=2023-12-15, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1772700081860, onlineIssueDateStr=2026-03-05, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1772700081860, creator=13701087609, updateTime=1772700081860, updator=13701087609, issue=Issue{id=1236357010644586638, tenantId=1146029695717560320, journalId=1235980733773295621, year='2023', volume='32', issue='23', pageStart='2329', pageEnd='2440', issueExtLink='null', onlineDate='null', pubDate='null', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1772700081740, creator=13701087609, updateTime=1772700436936, updator=13701087609, preIssue=null, nextIssue=null, ext={EN=IssueExt(id=1236358500507513194, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1236357010644586638, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1236358500507513195, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1236357010644586638, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null}, startPage=2360, endPage=2365, ext={EN=ArticleExt(id=1236357011403755664, articleId=1236357011147903118, tenantId=1146029695717560320, journalId=1235980733773295621, language=EN, title=Trilaciclib combined with topotecan as second-line treatment for extensive-stage small-cell lung cancer: a case report and literature review, columnId=null, journalTitle=Chinese Journal of New Drugs, columnName=null, runingTitle=null, highlight=null, articleAbstract=

Small cell lung cancer (SCLC) is characterized by a high degree of malignancy, with poor prognosis and high-growth fraction. About two-thirds of patients have developed distant metastasis at the time of diagnosis with rapid disease progression and high recurrence rates. Currently, topotecan-based chemotherapy remains the standard second-line treatment of SCLC with unfavorable disease remission, and less than one-fourth of patients have benefited from its efficacy. Chemotherapy-induced myelosuppression (CIM) is the most common toxicity in cancer chemotherapy, and severe CIM will reduce the dose intensity and anti-tumor efficacy of chemotherapy. Trilaciclib is a short-acting intravenous cyclin-dependent kinase 4/6 (CDK4/6) inhibitor administered prior to chemotherapy to preserve hematopoietic stem and progenitor cells and immune system function during chemotherapy, which has been approved by NMPA for prevention of CIM in SCLC in July 2022. Previous results showed that trilaciclib yielded favorable bone marrow protection during chemotherapy, but its anti-tumor effects in second-line treatment of SCLC have not been determined. This paper reports a case of a patient with advanced small-cell lung cancer with multiple metastases who obtained progression-free survival time of more than 1 year using trilaciclib combined with topotecan as second-line treatment.

, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, authorCompany=null, fund=null, authors=null, authorsList=Jing YUAN, Wei-ping LU, Guo-dong XIAO, Hui-jie FAN), CN=ArticleExt(id=1236357011831574679, articleId=1236357011147903118, tenantId=1146029695717560320, journalId=1235980733773295621, language=CN, title=曲拉西利联合拓扑替康二线治疗广泛期小细胞肺癌1例及文献分析, columnId=1236357011470864530, journalTitle=中国新药杂志, columnName=肿瘤治疗相关骨髓抑制防治进展专题, runingTitle=null, highlight=null, articleAbstract=

小细胞肺癌(SCLC)恶性程度高、预后差,约2/3的患者在确诊时已发生远处转移,疾病进展迅速,复发率高。目前,以拓扑替康为主的化疗方案仍然是SCLC二线治疗的标准方案,但疾病缓解时间短,受益于其疗效的患者不足1/4。骨髓抑制(CIM)是肿瘤化疗中最常见的毒副反应,严重的骨髓抑制会降低化疗的剂量强度和抗肿瘤疗效。曲拉西利是一种短效、可逆的细胞周期蛋白依赖性激酶(CDK)4/6抑制剂,2022年7月已获批用于SCLC化疗所致骨髓抑制的预防治疗。已有研究表明,曲拉西利具有较好的骨髓保护作用,其抗肿瘤作用仍需进一步探讨。本文报道1例伴有多发转移的晚期SCLC患者采用“曲拉西利联合拓扑替康二线治疗方案”获得超过1年无进展生存时间的病例。

, correspAuthors=null, authorNote=null, correspAuthorsNote=
樊慧杰,女,主任医师,主要从事肺癌、乳腺癌、食管癌、胃癌、结直肠癌、泌尿生殖系统及骨与软组织肿瘤等多种恶性肿瘤的诊断及治疗。E-mail:
, copyrightStatement=null, copyrightOwner=《中国新药杂志》有限公司, extLink=null, articleAbsUrl=null, sourceXml=6X2/VD9YTI1zCbhndNMgZg==, magXml=Q9zY8kn93H63dTNHIAMXUg==, pdfUrl=null, pdf=rXbbOfIwf6rSJRLRtMaHxQ==, pdfFileSize=7654837, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=jC/bXFA14av/p4OCvlGfaw==, mapNumber=null, authorCompany=null, fund=null, authors=

袁静,女,副主任医师,主要从事恶性肿瘤及肺癌的治疗及研究。E-mail:

, authorsList=袁静, 卢卫平, 肖国栋, 樊慧杰)}, authors=[Author(id=1236357012158730401, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=157135235@qq.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1236357012246810790, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, authorId=1236357012158730401, language=EN, stringName=Jing YUAN, firstName=Jing, middleName=null, lastName=YUAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1236357012376834219, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, authorId=1236357012158730401, language=CN, stringName=袁静, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=郑州大学第一附属医院肿瘤科,郑州 450052, bio={"content":"

袁静,女,副主任医师,主要从事恶性肿瘤及肺癌的治疗及研究。E-mail:

"}, bioImg=null, bioContent=

袁静,女,副主任医师,主要从事恶性肿瘤及肺癌的治疗及研究。E-mail:

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1236357012066455706, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, xref=null, ext=[AuthorCompanyExt(id=1236357012070650011, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, companyId=1236357012066455706, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China), AuthorCompanyExt(id=1236357012079038621, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, companyId=1236357012066455706, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=郑州大学第一附属医院肿瘤科,郑州 450052)])]), Author(id=1236357012490080431, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1236357012578160819, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, authorId=1236357012490080431, language=EN, stringName=Wei-ping LU, firstName=Wei-ping, middleName=null, lastName=LU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1236357012674629816, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, authorId=1236357012490080431, language=CN, stringName=卢卫平, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=郑州大学第一附属医院肿瘤科,郑州 450052, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1236357012066455706, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, xref=null, ext=[AuthorCompanyExt(id=1236357012070650011, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, companyId=1236357012066455706, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China), AuthorCompanyExt(id=1236357012079038621, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, companyId=1236357012066455706, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=郑州大学第一附属医院肿瘤科,郑州 450052)])]), Author(id=1236357012750127295, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1236357012829819076, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, authorId=1236357012750127295, language=EN, stringName=Guo-dong XIAO, firstName=Guo-dong, middleName=null, lastName=XIAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1236357012922093770, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, authorId=1236357012750127295, language=CN, stringName=肖国栋, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=郑州大学第一附属医院肿瘤科,郑州 450052, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1236357012066455706, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, xref=null, ext=[AuthorCompanyExt(id=1236357012070650011, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, companyId=1236357012066455706, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China), AuthorCompanyExt(id=1236357012079038621, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, companyId=1236357012066455706, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=郑州大学第一附属医院肿瘤科,郑州 450052)])]), Author(id=1236357012985008335, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=doctor_huijiefan@163.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1236357013064700119, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, authorId=1236357012985008335, language=EN, stringName=Hui-jie FAN, firstName=Hui-jie, middleName=null, lastName=FAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1236357013156974814, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, authorId=1236357012985008335, language=CN, stringName=樊慧杰, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=郑州大学第一附属医院肿瘤科,郑州 450052, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1236357012066455706, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, xref=null, ext=[AuthorCompanyExt(id=1236357012070650011, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, companyId=1236357012066455706, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China), AuthorCompanyExt(id=1236357012079038621, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, companyId=1236357012066455706, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=郑州大学第一附属医院肿瘤科,郑州 450052)])])], keywords=[Keyword(id=1236357013249249510, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, language=EN, orderNo=1, keyword=small-cell lung cancer), Keyword(id=1236357013328941290, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, language=EN, orderNo=2, keyword=chemotherapy), Keyword(id=1236357013396050157, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, language=EN, orderNo=3, keyword=myelosuppression), Keyword(id=1236357013484130548, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, language=EN, orderNo=4, keyword=trilaciclib), Keyword(id=1236357013551239418, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, language=CN, orderNo=1, keyword=小细胞肺癌), Keyword(id=1236357013626736893, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, language=CN, orderNo=2, keyword=化疗), Keyword(id=1236357013681262852, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, language=CN, orderNo=3, keyword=骨髓抑制), Keyword(id=1236357013744177420, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, language=CN, orderNo=4, keyword=曲拉西利)], refs=null, funds=null, companyList=[AuthorCompany(id=1236357012066455706, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, xref=null, ext=[AuthorCompanyExt(id=1236357012070650011, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, companyId=1236357012066455706, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China), AuthorCompanyExt(id=1236357012079038621, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236357011147903118, companyId=1236357012066455706, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=郑州大学第一附属医院肿瘤科,郑州 450052)])], figs=null, attaches=null, journal=Journal(id=1235980159023624194, delFlag=0, nameCn=中国新药杂志, nameEn=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, issn=1003-3734, eissn=null, cn=11-2850/R, coden=ZXZHA6, periodic=3, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of New Drugs, journalRemark=null, publicationField=null, createdTime=1772610233314, updatedTime=1772610649152, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=C, firstLetterEn=C, subjectCode=Life Sciences, subjectName=null, subjectCodeEn=Life Sciences, subjectNameEn=null, picCn=ohPEEN//Vz1tDT3ZBNTp4Q==, picEn=f9WK9bvTM4guTmS/iGhOMg==, jcr=null, cjcr=null, exts=[JournalExt(id=1235981903275290962, language=CN, name=中国新药杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1772610649174, updatedTime=1772610649174, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1235981903338205523, language=EN, name=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1772610649189, updatedTime=1772610649189, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1235980733773295621, websiteList=[Website(id=1235982099191222761, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/CN, language=CN, createTime=1772610695884, createBy=18614031015, updateTime=1772610860397, updateBy=18614031015, name=中国新药杂志-中文, tplId=1146099689490845704, title=中国新药杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983918629966444, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=articleTextType, value=kx, createTime=1772611129672, updateTime=1772611129672, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918604800617, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=banner, value=null, createTime=1772611129666, updateTime=1772611129666, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918655132271, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=grayFlag, value=0, createTime=1772611129678, updateTime=1772611129678, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918596412008, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611129664, updateTime=1772611129664, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918667715185, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=minRunFlag, value=0, createTime=1772611129681, updateTime=1772611129681, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918617383531, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic, createTime=1772611129669, updateTime=1772611129669, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918659326576, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=silenceFlag, value=0, createTime=1772611129679, updateTime=1772611129679, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918613189226, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1772611129668, updateTime=1772611129668, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918634160749, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeColor, value=null, createTime=1772611129673, updateTime=1772611129673, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918646743662, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeStyle, value=null, createTime=1772611129676, updateTime=1772611129676, creator=18614031015, updator=18614031015)]), Website(id=1235982099270914542, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/EN, language=EN, createTime=1772610695903, createBy=18614031015, updateTime=1772610875891, updateBy=18614031015, name=中国新药杂志-英文, tplId=1146101810881728533, title=Chinese Journal of New Drugs, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983955829248630, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=articleTextType, value=kx, createTime=1772611138541, updateTime=1772611138541, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955804082803, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=banner, value=null, createTime=1772611138535, updateTime=1772611138535, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955854414457, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=grayFlag, value=0, createTime=1772611138547, updateTime=1772611138547, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955795694194, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611138533, updateTime=1772611138533, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955866997371, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=minRunFlag, value=0, createTime=1772611138550, updateTime=1772611138550, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955820860021, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic, createTime=1772611138539, updateTime=1772611138539, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955862803066, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=silenceFlag, value=0, createTime=1772611138549, updateTime=1772611138549, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955812471412, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1772611138537, updateTime=1772611138537, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955837637239, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeColor, value=null, createTime=1772611138543, updateTime=1772611138543, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955846025848, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeStyle, value=null, createTime=1772611138545, updateTime=1772611138545, creator=18614031015, updator=18614031015)])], journalTitle=中国新药杂志, weixinUrl=null, journalUrl=http://www.newdrug.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of New Drugs, journalPhotoCn=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPhotoEn=f9WK9bvTM4guTmS/iGhOMg==, journalFirstLetter=C, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/Y2023/V32/I23/2360, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/Y2023/V32/I23/2360, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/PDF/Y2023/V32/I23/2360, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/PDF/Y2023/V32/I23/2360, aliStartDate=null, aliEndDate=null, collectionFlag=false, citedCount=null, citedUrl=null, reference=null)
收藏切换
曲拉西利联合拓扑替康二线治疗广泛期小细胞肺癌1例及文献分析
收藏切换
PDF下载
袁静 , 卢卫平 , 肖国栋 , 樊慧杰
中国新药杂志 | 肿瘤治疗相关骨髓抑制防治进展专题 2023,32(23): 2360-2365
收起
收藏切换
中国新药杂志 | 肿瘤治疗相关骨髓抑制防治进展专题 2023, 32(23): 2360-2365
曲拉西利联合拓扑替康二线治疗广泛期小细胞肺癌1例及文献分析
全屏
袁静 , 卢卫平, 肖国栋, 樊慧杰
作者信息
  • 郑州大学第一附属医院肿瘤科,郑州 450052
  • 袁静,女,副主任医师,主要从事恶性肿瘤及肺癌的治疗及研究。E-mail:

通讯作者:

樊慧杰,女,主任医师,主要从事肺癌、乳腺癌、食管癌、胃癌、结直肠癌、泌尿生殖系统及骨与软组织肿瘤等多种恶性肿瘤的诊断及治疗。E-mail:
Trilaciclib combined with topotecan as second-line treatment for extensive-stage small-cell lung cancer: a case report and literature review
Jing YUAN , Wei-ping LU, Guo-dong XIAO, Hui-jie FAN
Affiliations
  • Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
出版时间: 2023-12-15
文章导航
收藏切换

小细胞肺癌(SCLC)恶性程度高、预后差,约2/3的患者在确诊时已发生远处转移,疾病进展迅速,复发率高。目前,以拓扑替康为主的化疗方案仍然是SCLC二线治疗的标准方案,但疾病缓解时间短,受益于其疗效的患者不足1/4。骨髓抑制(CIM)是肿瘤化疗中最常见的毒副反应,严重的骨髓抑制会降低化疗的剂量强度和抗肿瘤疗效。曲拉西利是一种短效、可逆的细胞周期蛋白依赖性激酶(CDK)4/6抑制剂,2022年7月已获批用于SCLC化疗所致骨髓抑制的预防治疗。已有研究表明,曲拉西利具有较好的骨髓保护作用,其抗肿瘤作用仍需进一步探讨。本文报道1例伴有多发转移的晚期SCLC患者采用“曲拉西利联合拓扑替康二线治疗方案”获得超过1年无进展生存时间的病例。

小细胞肺癌  /  化疗  /  骨髓抑制  /  曲拉西利

Small cell lung cancer (SCLC) is characterized by a high degree of malignancy, with poor prognosis and high-growth fraction. About two-thirds of patients have developed distant metastasis at the time of diagnosis with rapid disease progression and high recurrence rates. Currently, topotecan-based chemotherapy remains the standard second-line treatment of SCLC with unfavorable disease remission, and less than one-fourth of patients have benefited from its efficacy. Chemotherapy-induced myelosuppression (CIM) is the most common toxicity in cancer chemotherapy, and severe CIM will reduce the dose intensity and anti-tumor efficacy of chemotherapy. Trilaciclib is a short-acting intravenous cyclin-dependent kinase 4/6 (CDK4/6) inhibitor administered prior to chemotherapy to preserve hematopoietic stem and progenitor cells and immune system function during chemotherapy, which has been approved by NMPA for prevention of CIM in SCLC in July 2022. Previous results showed that trilaciclib yielded favorable bone marrow protection during chemotherapy, but its anti-tumor effects in second-line treatment of SCLC have not been determined. This paper reports a case of a patient with advanced small-cell lung cancer with multiple metastases who obtained progression-free survival time of more than 1 year using trilaciclib combined with topotecan as second-line treatment.

small-cell lung cancer  /  chemotherapy  /  myelosuppression  /  trilaciclib
袁静, 卢卫平, 肖国栋, 樊慧杰. 曲拉西利联合拓扑替康二线治疗广泛期小细胞肺癌1例及文献分析. 中国新药杂志, 2023 , 32 (23) : 2360 -2365 .
Jing YUAN, Wei-ping LU, Guo-dong XIAO, Hui-jie FAN. Trilaciclib combined with topotecan as second-line treatment for extensive-stage small-cell lung cancer: a case report and literature review[J]. Chinese Journal of New Drugs, 2023 , 32 (23) : 2360 -2365 .
2023年第32卷第23期
PDF下载
45
18
引用本文
BibTeX
文章信息
  • 首发时间:2026-03-05
  • 出版时间:2023-12-15
补充材料
相关文章
文章信息
作者
出版历史
  • 录用日期:2023-09-18
基金
作者信息
    郑州大学第一附属医院肿瘤科,郑州 450052

通讯作者:

樊慧杰,女,主任医师,主要从事肺癌、乳腺癌、食管癌、胃癌、结直肠癌、泌尿生殖系统及骨与软组织肿瘤等多种恶性肿瘤的诊断及治疗。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgxyzz/CN/1236357011147903118
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏